Genocea Biosciences, Inc. announced that Ron Cooper has joined its board of directors, effective immediately. Mr. Cooper currently serves as president and chief executive officer at Albireo Ltd. Prior to joining Albireo, he spent more than 25 years at Bristol-Myers Squibb, where he worked in five different countries and held positions of increasing responsibility in sales, marketing and general management, culminating as President of Europe.